UNSPSC 41142101: Ammonium hydroxide titrants

In this classification, this entry connotes a titrant of Ammonium hydroxide used as a reagent in clinical chemistry testing.

UNSPSC 41142101 Ammonium hydroxide titrants (Commodity) encompasses chemical reagents and reference standards used in forensic drug analysis, toxicology screening, and laboratory testing operations. State and local governments procure these materials primarily through forensic laboratories, public health departments, and law enforcement agencies to conduct substance identification, method validation, and evidentiary analysis. The scope includes direct ELISA testing kits for controlled-substance screening, certified drug reference standards with defined purity and uncertainty tolerances, DNA screening and sizing reagent kits, and phosphate-buffered saline solutions. Issuing bodies span state law enforcement and criminal justice departments, county forensic laboratories, and state health and human services agencies; the Texas Department of Public Safety, Texas Department of Criminal Justice, Texas Health and Human Services Commission, Pinellas County Florida, and the Illinois Department of Financial and Professional Regulation appear as active buyers in recent solicitations.

Recent activity clusters in Texas and Florida. The Texas Department of Public Safety issued IFB 405-26R0008445A on July 9, 2026, for 12 line items of Direct ELISA immunalysis reagent kits (cannabinoids, opiates, PCP, amphetamines, barbiturates, methamphetamine, cocaine, benzodiazepines, oxycodone, carisoprodol, and zolpidem) plus phosphate-buffered saline, with responses due July 23, 2026. Pinellas County, Florida, in partnership with the Florida Department of Law Enforcement, posted Invitation to Quote 26-0305-ITQ on April 23, 2026, for 131 line items of certified drug reference standards meeting ISO/IEC 17025 and ISO 17034 accreditation standards with firm pricing for 12 months, funded through the Paul Coverdell Forensic Sciences Improvement Act Program at $72,126.85 total ($49,034.00 designated for supplies including drug standards). The Texas Health and Human Services Commission issued IFB HHS0016902v2 for QIAxcel and QIAamp DNA screening kits (seven line items including alignment and size markers) with a response deadline of January 29, 2026 and anticipated contract value of $25,050.00 to $30,000.00 based on fiscal year 2025 historical spend. Bidders on these solicitations must meet accreditation standards, provide certificates of analysis, hold DEA licensing where required, and comply with HUB subcontracting plans or SBE preferences where applicable.